Retrospective Cohort Study of Shear-Wave Elastography and Computed Tomography Enterography in Crohn's Disease
Overview
Affiliations
Distinguishing between inflammatory and fibrotic lesions drastically influences treatment decision-making regarding Crohn's disease. However, it is challenging to distinguish these two phenotypes before surgery. This study investigates the diagnostic yield of shear-wave elastography and computed tomography enterography to distinguish intestinal phenotypes in Crohn's disease. Thirty-seven patients (mean age, 29.51 ± 11.52; 31 men) were evaluated with average value of shear-wave elastography (Emean) and computed tomography enterography (CTE) scores. The results demonstrated that a positive correlation between the Emean and fibrosis (Spearman's r = 0.653, = 0.000). The cut-off value for fibrotic lesions was 21.30 KPa (AUC: 0.877, sensitivity: 88.90%, specificity: 89.50%, 95% CI:0.755~0.999, = 0.000). The CTE score showed a positive correlation with inflammation (Spearman's r = 0.479, = 0.003), and a 4.5-point grading system was the optimal cut-off value for inflammatory lesions (AUC: 0.766, sensitivity: 73.70%, specificity: 77.80%, 95% CI: 0.596~0.936, = 0.006). Combining these two metrics improved the diagnostic performance and specificity (AUC: 0.918, specificity: 94.70%, 95% CI: 0.806~1.000, = 0.000). In conclusion, shear-wave elastography can be used to help detect fibrotic lesions and the computed tomography enterography score emerged as a feasible predictor of inflammatory lesions. The combination of these two imaging techniques is proposed to distinguish intestinal predominant phenotypes.
Kuczynska M, Zbroja M, Drelich-Zbroja A Diagnostics (Basel). 2024; 14(20).
PMID: 39451622 PMC: 11506928. DOI: 10.3390/diagnostics14202299.
Current Developments and Role of Intestinal Ultrasound including the Advent of AI.
Tagliamonte G, Santagata F, Fraquelli M Diagnostics (Basel). 2024; 14(7).
PMID: 38611672 PMC: 11011653. DOI: 10.3390/diagnostics14070759.
Rajabzadeh F, Hassannejad E, Akhlaghipour I, Imen M, Babazadeh Baghan A, Goshayeshi L Health Sci Rep. 2023; 6(10):e1619.
PMID: 37822842 PMC: 10563170. DOI: 10.1002/hsr2.1619.